Volume : 09, Issue : 10, October – 2022



Authors :

Teflah Al Mufarrih,Dr. Mona Alshahed, Ahmed Almutairi, Dr. Maithaa Alharfi, Rehanna Kadhim Alsadiq

Abstract :

Introduction: Male breast cancer may become more common, emphasizing the importance of early detection. The diagnosing male breast cancer is more challenging due to the lack of sufficient information on screening guidelines in men, limited awareness, and education, as well as a general inclination among men to delay care. The diagnosis of male breast cancer can be made in most cases by triple assessment: clinical evaluation, radiologic assessment (mammography and ultrasound examination), and tissue biopsy (fine-needle aspiration cytology or core biopsy).
Main aim: To assess the prevalence of male breast cancer as well as the correlation between the radiological finding and BIRAD classification which was given with the pathological biopsy result.
Methodology: Retrospective cohort study of 315 male patients, who underwent mammography and ultrasound to diagnose different breast symptoms in radiology department at Prince Sultan Medical Military City- Riyadh, Saudi Arabia between January 2016, and December 2020. Evaluated variables include age, symptoms, site of complain, radiological findings, and biopsy result. All ultrasound and mammographic images accessed via picture archiving and communication system (PACS). The collected data was statistically analyzed using SPSS version 20. Chi-square tests and Logistic regression models was used. Associations were considered statistically significant at P value < 0.05.
Main Results: The result described all of sample men 275 (87%) presented with the new onset of breast Mass, 3% of them complained mainly of pain, and 4% presented with nipple discharge. Only 6% of the 315 subjects came for screening due to positive family history.
The correlation between the BIRAD classification and the final pathological diagnosis was significant (p-value < 0.001), as the biopsy results of 15 (5%) patients who were classified radiologically as BIRAD 4 or BIRAD 5 were found to be malignant. The remaining 300 (95%) was benign, including one patient, who was classified radiologically as BIRAD 4.
Conclusion: Breast carcinoma in the male population, is a rare disease. Despite this, there has been a surge in incidence over the past few years. The diagnosis is usually delayed until the disease has progressed and reached later stage. Public awareness should, therefore, be increased and breast cancer should be considered in the differential diagnosis of a male patient that presents with breast swelling. The majority of sampled patient found to have of benign pathology, commonly gynecomastia, while most of the malignant cases are invasive ductal carcinoma.

Cite This Article:

Please cite this article in Teflah Al Mufarrih et al, The Prevalence Of Male Breast Cancer At Prince Sultan Medical Military City., Indo Am. J. P. Sci, 2022; 09(10).


1. Abdelwahab Yousef, A. J. (2017). Male Breast Cancer: Epidemiology and Risk Factors. Semin Oncol, 44(4), 267-272. https://doi.org/10.1053/j.seminoncol.2017.11.002
2. Adibelli, Z. H., Oztekin, O., Gunhan-Bilgen, I., Postaci, H., Uslu, A., & Ilhan, E. (2010). Imaging characteristics of male breast disease. Breast J, 16(5), 510-518. https://doi.org/10.1111/j.1524-4741.2010.00951.x
3. Agrawal, A., Ayantunde, A. A., Rampaul, R., & Robertson, J. F. (2007). Male breast cancer: a review of clinical management. Breast Cancer Res Treat, 103(1), 11-21. https://doi.org/10.1007/s10549-006-9356-z
4. AlSharif, S., Alshamrani, K. M., Scaranelo, A., Khoumais, N., Subahi, A., & Mesurolle, B. (2021). Unusual Male Breast Lesions. J Clin Imaging Sci, 11, 21. https://doi.org/10.25259/jcis_43_2021
5. Bagley, C. S., Wesley, M. N., Young, R. C., & Lippman, M. E. (1987). Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol, 10(1), 55-60. https://doi.org/10.1097/00000421-198702000-00013
6. Barreau, B., de Mascarel, I., Feuga, C., MacGrogan, G., Dilhuydy, M. H., Picot, V., Dilhuydy, J. M., de Lara, C. T., Bussières, E., & Schreer, I. (2005). Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. Eur J Radiol, 54(1), 55-61. https://doi.org/10.1016/j.ejrad.2004.11.019
7. Board, P. A. T. E. (2021). Male Breast Cancer Treatment (PDQ®). PDQ cancer information summaries [internet].
8. Brinton, L. A., Carreon, J. D., Gierach, G. L., McGlynn, K. A., & Gridley, G. (2010). Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat, 119(1), 185-192. https://doi.org/10.1007/s10549-009-0379-0
9. Brinton, L. A., Richesson, D. A., Gierach, G. L., Lacey, J. V., Jr., Park, Y., Hollenbeck, A. R., & Schatzkin, A. (2008). Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst, 100(20), 1477-1481. https://doi.org/10.1093/jnci/djn329
10. Capasso, R., Sica, A., D’Amora, M., Mostardi, M., Martella, I., Totaro, M., Della Casa, G., Vallara, M., Pesce, A., & Gatta, G. (2016). Gynecomastia: a common indication for mammography in men of all age. Acta Biomed, 87(3), 63-68.
11. Charlot, M., Béatrix, O., Chateau, F., Dubuisson, J., Golfier, F., Valette, P. J., & Réty, F. (2013). Pathologies of the male breast. Diagn Interv Imaging, 94(1), 26-37. https://doi.org/10.1016/j.diii.2012.10.011
12. Chau, A., Jafarian, N., & Rosa, M. (2016). Male Breast: Clinical and Imaging Evaluations of Benign and Malignant Entities with Histologic Correlation. Am J Med, 129(8), 776-791. https://doi.org/10.1016/j.amjmed.2016.01.009
13. Chesebro, A. L., Rives, A. F., & Shaffer, K. (2019). Male Breast Disease: What the Radiologist Needs to Know. Curr Probl Diagn Radiol, 48(5), 482-493. https://doi.org/10.1067/j.cpradiol.2018.07.003
14. Co, M., Lee, A., & Kwong, A. (2020). Delayed presentation, diagnosis, and psychosocial aspects of male breast cancer. Cancer Med, 9(10), 3305-3309. https://doi.org/10.1002/cam4.2953
15. Cutuli, B., Le-Nir, C. C., Serin, D., Kirova, Y., Gaci, Z., Lemanski, C., De Lafontan, B., Zoubir, M., Maingon, P., Mignotte, H., de Lara, C. T., Edeline, J., Penault-Llorca, F., Romestaing, P., Delva, C., Comet, B., & Belkacemi, Y. (2010). Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol, 73(3), 246-254. https://doi.org/10.1016/j.critrevonc.2009.04.002
16. Darkeh, M. H. S. E., & Azavedo, E. (2014). Male breast cancer clinical features, risk factors, and current diagnostic and therapeutic approaches. International Journal of Clinical Medicine, 2014.
17. Del Riego, J., Pitarch, M., Codina, C., Nebot, L., Andreu, F. J., Aparicio, O., Medina, A., & Martín, A. (2020). Multimodality approach to the nipple-areolar complex: a pictorial review and diagnostic algorithm. Insights into Imaging, 11(1), 1-27.
18. Donegan, W. L., Redlich, P. N., Lang, P. J., & Gall, M. T. (1998). Carcinoma of the breast in males: a multiinstitutional survey. Cancer, 83(3), 498-509. https://doi.org/10.1002/(sici)1097-0142(19980801)83:3<498::aid-cncr19>3.0.co;2-r
19. Draghi, F., Tarantino, C. C., Madonia, L., & Ferrozzi, G. (2011). Ultrasonography of the male breast. J Ultrasound, 14(3), 122-129. https://doi.org/10.1016/j.jus.2011.06.004
20. Erhan, Y., Zekioglu, O., & Erhan, Y. (2006). Invasive lobular carcinoma of the male breast. Can J Surg, 49(5), 365-366.
21. Ewertz, M., Holmberg, L., Tretli, S., Pedersen, B. V., & Kristensen, A. (2001). Risk factors for male breast cancer–a case-control study from Scandinavia. Acta Oncol, 40(4), 467-471. https://doi.org/10.1080/028418601750288181
22. Fentiman, I. S., Fourquet, A., & Hortobagyi, G. N. (2006). Male breast cancer. Lancet, 367(9510), 595-604. https://doi.org/10.1016/s0140-6736(06)68226-3
23. Fentiman, I. S., Fourquet, A., & Hortobagyi, G. N. (2006). Male breast cancer. The Lancet, 367(9510), 595-604.
24. Gao, Y., Goldberg, J. E., Young, T. K., Babb, J. S., Moy, L., & Heller, S. L. (2019). Breast Cancer Screening in High-Risk Men: A 12-year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes. Radiology, 293(2), 282-291. https://doi.org/10.1148/radiol.2019190971
25. Gao, Y., Heller, S. L., & Moy, L. (2018). Male Breast Cancer in the Age of Genetic Testing: An Opportunity for Early Detection, Tailored Therapy, and Surveillance. Radiographics, 38(5), 1289-1311. https://doi.org/10.1148/rg.2018180013
26. Greenwood, H. I., Heller, S. L., Kim, S., Sigmund, E. E., Shaylor, S. D., & Moy, L. (2013). Ductal carcinoma in situ of the breasts: review of MR imaging features. Radiographics, 33(6), 1569-1588. https://doi.org/10.1148/rg.336125055
27. Gucalp, A., Traina, T. A., Eisner, J. R., Parker, J. S., Selitsky, S. R., Park, B. H., Elias, A. D., Baskin-Bey, E. S., & Cardoso, F. (2019). Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat, 173(1), 37-48. https://doi.org/10.1007/s10549-018-4921-9
28. Günhan-Bilgen, I., Bozkaya, H., Ustün, E., & Memiş, A. (2002). Male breast disease: clinical, mammographic, and ultrasonographic features. Eur J Radiol, 43(3), 246-255. https://doi.org/10.1016/s0720-048x(01)00483-1
29. Hofvind, S., Iversen, B. F., Eriksen, L., Styr, B. M., Kjellevold, K., & Kurz, K. D. (2011). Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening. Acta Radiol, 52(5), 481-487. https://doi.org/10.1258/ar.2011.100357
30. Huang, Y., Xiao, Q., Sun, Y., Li, Q., Wang, S., & Gu, Y. (2020). Differential diagnosis of benign and malignant male breast lesions in mammography. Eur J Radiol, 132, 109339. https://doi.org/10.1016/j.ejrad.2020.109339
31. Iuanow, E., Kettler, M., & Slanetz, P. J. (2011). Spectrum of disease in the male breast. AJR Am J Roentgenol, 196(3), W247-259. https://doi.org/10.2214/ajr.09.3994
32. jafari, m., Olfatbakhsh, A., & rezaei-kalantari, k. (2017). Male Breast Cancer; A Review of Risk Factors and Clinical and Radiological Features [Review Article]. Multidisciplinary Cancer Investigation, 1(4), 1-6. https://doi.org/10.21859/mci-01044
33. Johansen Taber, K. A., Morisy, L. R., Osbahr, A. J., 3rd, & Dickinson, B. D. (2010). Male breast cancer: risk factors, diagnosis, and management (Review). Oncol Rep, 24(5), 1115-1120. https://doi.org/10.3892/or_00000962
34. Kalli, S., Lanfranchi, M., Alexander, A., Makim, S., & Freer, P. E. (2016). Spectrum of Extramammary Malignant Neoplasms in the Breast With Radiologic-Pathologic Correlation. Curr Probl Diagn Radiol, 45(6), 392-401. https://doi.org/10.1067/j.cpradiol.2015.07.012
35. Kopans, D. B. (2007). Breast imaging. Lippincott Williams & Wilkins.
36. Korde, L. A., Zujewski, J. A., Kamin, L., Giordano, S., Domchek, S., Anderson, W. F., Bartlett, J. M., Gelmon, K., Nahleh, Z., Bergh, J., Cutuli, B., Pruneri, G., McCaskill-Stevens, W., Gralow, J., Hortobagyi, G., & Cardoso, F. (2010). Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol, 28(12), 2114-2122. https://doi.org/10.1200/jco.2009.25.5729
37. Lattin, G. E., Jr., Jesinger, R. A., Mattu, R., & Glassman, L. M. (2013). From the radiologic pathology archives: diseases of the male breast: radiologic-pathologic correlation. Radiographics, 33(2), 461-489. https://doi.org/10.1148/rg.332125208
38. Mainiero, M. B., Lourenco, A. P., Barke, L. D., Argus, A. D., Bailey, L., Carkaci, S., D’Orsi, C., Green, E. D., Holley, S. O., Jokich, P. M., Lee, S. J., Mahoney, M. C., Moy, L., Slanetz, P. J., Trikha, S., Yepes, M. M., & Newell, M. S. (2015). ACR Appropriateness Criteria Evaluation of the Symptomatic Male Breast. J Am Coll Radiol, 12(7), 678-682. https://doi.org/10.1016/j.jacr.2015.03.024
39. Mele, M., Jensen, V., Wronecki, A., & Lelkaitis, G. (2011). Myofibroblastoma of the breast: Case report and literature review. Int J Surg Case Rep, 2(6), 93-96. https://doi.org/10.1016/j.ijscr.2011.02.006
40. Muñoz Carrasco, R., Alvarez Benito, M., Muñoz Gomariz, E., Raya Povedano, J. L., & Martínez Paredes, M. (2010). Mammography and ultrasound in the evaluation of male breast disease. Eur Radiol, 20(12), 2797-2805. https://doi.org/10.1007/s00330-010-1867-7
41. Nguyen, C., Kettler, M. D., Swirsky, M. E., Miller, V. I., Scott, C., Krause, R., & Hadro, J. A. (2013). Male breast disease: pictorial review with radiologic-pathologic correlation. Radiographics, 33(3), 763-779. https://doi.org/10.1148/rg.333125137
42. Niell, B. L., Lourenco, A. P., Moy, L., Baron, P., Didwania, A. D., diFlorio-Alexander, R. M., Heller, S. L., Holbrook, A. I., Le-Petross, H. T., Lewin, A. A., Mehta, T. S., Slanetz, P. J., Stuckey, A. R., Tuscano, D. S., Ulaner, G. A., Vincoff, N. S., Weinstein, S. P., & Newell, M. S. (2018). ACR Appropriateness Criteria(®) Evaluation of the Symptomatic Male Breast. J Am Coll Radiol, 15(11s), S313-s320. https://doi.org/10.1016/j.jacr.2018.09.017
43. Nofal, M. N., & Yousef, A. J. (2019). The diagnosis of male breast cancer. Neth J Med, 77(10), 356-359.
44. Omene, C., & Tiersten, A. (2010). The differences between male and female breast cancer. In Principles of gender-specific medicine (pp. 459-472). Elsevier.
45. Önder, Ö., Azizova, A., Durhan, G., Elibol, F. D., Akpınar, M. G., & Demirkazık, F. (2020). Imaging findings and classification of the common and uncommon male breast diseases. Insights Imaging, 11(1), 27. https://doi.org/10.1186/s13244-019-0834-3
46. Ottini, L., Capalbo, C., Rizzolo, P., Silvestri, V., Bronte, G., Rizzo, S., & Russo, A. (2010). HER2-positive male breast cancer: an update. Breast Cancer (Dove Med Press), 2, 45-58. https://doi.org/10.2147/bctt.S6519
47. Ottini, L., Rizzolo, P., Zanna, I., Falchetti, M., Masala, G., Ceccarelli, K., Vezzosi, V., Gulino, A., Giannini, G., Bianchi, S., Sera, F., & Palli, D. (2009). BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy. Breast Cancer Res Treat, 116(3), 577-586. https://doi.org/10.1007/s10549-008-0194-z
48. Rosenblatt, K. A., Thomas, D. B., McTiernan, A., Austin, M. A., Stalsberg, H., Stemhagen, A., Thompson, W. D., Curnen, M. G., Satariano, W., Austin, D. F., & et al. (1991). Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst, 83(12), 849-854. https://doi.org/10.1093/jnci/83.12.849
49. Ruddy, K. J., & Winer, E. P. (2013). Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol, 24(6), 1434-1443. https://doi.org/10.1093/annonc/mdt025
50. Rudlowski, C. (2008). Male Breast Cancer. Breast Care (Basel), 3(3), 183-189. https://doi.org/10.1159/000136825
51. Sarıca, Ö., Kahraman, A. N., Öztürk, E., & Teke, M. (2018). Efficiency of Imaging Modalities in Male Breast Disease: Can Ultrasound Give Additional Information for Assessment of Gynecomastia Evolution? Eur J Breast Health, 14(1), 29-34. https://doi.org/10.5152/ejbh.2017.3416
52. Scott-Conner, C. E., Jochimsen, P. R., Menck, H. R., & Winchester, D. J. (1999). An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery, 126(4), 775-780; discussion 780-771.
53. Sencha, A. N. (2014). Imaging of male breast cancer. Springer.
54. Sippo, D. A., Kulkarni, K., Carlo, P. D., Lee, B., Eisner, D., Cimino-Mathews, A., & Harvey, S. C. (2016). Metastatic Disease to the Breast From Extramammary Malignancies: A Multimodality Pictorial Review. Curr Probl Diagn Radiol, 45(3), 225-232. https://doi.org/10.1067/j.cpradiol.2015.07.001
55. Smith, J. A., Braunack-Mayer, A., & Wittert, G. (2006). What do we know about men’s help-seeking and health service use? Med J Aust, 184(2), 81-83. https://doi.org/10.5694/j.1326-5377.2006.tb00124.x
56. Suleimenova, D., Eghtedari, M., & Ojeda-Fournier, H. (2018). Evaluation of symptomatic male breast.
57. Tavassoli, F. (1999). Pathology of the breast, 2nd edn Applenton & Lange. In: Stanford.
58. Yalaza, M., İnan, A., & Bozer, M. (2016a). Male Breast Cancer. The journal of breast health, 12(1), 1-8. https://doi.org/10.5152/tjbh.2015.2711
59. Yalaza, M., İnan, A., & Bozer, M. (2016b). Male breast cancer. The journal of breast health, 12(1), 1.
60. Yen, P. P., Sinha, N., Barnes, P. J., Butt, R., & Iles, S. (2015). Benign and Malignant Male Breast Diseases: Radiologic and Pathologic Correlation. Can Assoc Radiol J, 66(3), 198-207. https://doi.org/10.1016/j.carj.2015.01.002
61. Yoney, A., Kucuk, A., & Unsal, M. (2009). Male breast cancer: a retrospective analysis. Cancer Radiother, 13(2), 103-107. https://doi.org/10.1016/j.canrad.2008.11.011
62. Yuan, W. H., Li, A. F., Chou, Y. H., Hsu, H. C., & Chen, Y. Y. (2018). Clinical and ultrasonographic features of male breast tumors: A retrospective analysis. PLoS One, 13(3), e0194651. https://doi.org/10.1371/journal.pone.0194651